Gilead Sciences Inc
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.61 | 5.66 | 5.36 | 5.56 | 6.02 | 6.01 | 5.30 | 5.64 | 6.20 | 6.32 | 5.55 | 6.28 | 24.50 | |
| 1.25 | 1.66 | 1.24 | 1.23 | 1.26 | 1.26 | 1.22 | 1.20 | 1.25 | 1.30 | 1.15 | 1.27 | 5.00 | |
| 4.36 | 4.00 | 4.12 | 4.32 | 4.76 | 4.76 | 4.07 | 4.45 | 4.94 | 5.03 | 4.40 | 5.01 | 19.50 | |
| 1.16 | 1.12 | 1.22 | 1.08 | 1.11 | 1.30 | 1.10 | 1.19 | 1.07 | 1.26 | 1.09 | 1.42 | 4.88 | |
| 1.05 | 0.60 | 0.51 | 0.46 | 0.35 | 0.79 | 0.40 | 0.40 | 0.42 | 0.52 | 0.44 | 1.55 | 2.94 | |
| 2.28 | 2.72 | 7.58 | 2.21 | 4.05 | 2.81 | 2.30 | 2.47 | 2.29 | 2.64 | 2.34 | 13.37 | 20.70 | |
| 2.09 | 1.28 | -3.47 | 2.11 | 0.71 | 1.95 | 1.78 | 1.97 | 2.65 | 2.38 | 2.15 | -8.36 | -1.12 | |
| 0.18 | 0.20 | 0.20 | 0.19 | 0.19 | 0.20 | 0.21 | 0.20 | 0.20 | 0.20 | 0.19 | 0.20 | 0.80 | |
| 1.84 | 1.32 | -3.60 | 1.64 | 0.76 | 1.72 | 1.31 | 1.94 | 2.90 | 1.66 | 2.06 | -8.25 | -1.57 | |
| 0.12 | 0.19 | -0.25 | 0.35 | -0.24 | 0.31 | 0.27 | 0.37 | 0.47 | -0.08 | 0.45 | 0.19 | 1.03 | |
| 1.73 | 1.14 | -3.34 | 1.29 | 1.00 | 1.42 | 1.04 | 1.56 | 2.43 | 1.74 | 1.61 | -8.44 | -2.61 | |
| 2.57 | 2.06 | -2.84 | 2.39 | 1.50 | 2.47 | 2.07 | 2.69 | 3.65 | 2.41 | 2.80 | -8.05 | 0.89 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.